Lonza Announces Adjusted Mid-Term Guidance 2022

Basel, Switzerland—Lonza has announced the adjustment of its Mid-Term Guidance 2022 to reflect the divestment of its former Water Care business unit and to emphasize its focus on growth along the Healthcare Continuum, a press release says.

Adjusted guidance is the following, according to the press release:

  • Sales of CHF 7.1 billion
  • CORE EBITDA margin of 30.5%
  • CORE RONOA 35%
  • Double-digit ROIC

Mark Funk, CEO of Lonza, said in the release, “This adjusted Mid-Term Guidance clearly demonstrates our focus on growing our businesses along the Healthcare Continuum while continuing to aim for operational excellence, productivity improvements, and attractive margins.”

The Mid-Term Guidance is based on the present business composition, the present macro-economic environment, current visibility, and constant exchange rates, the press release says.